Genetic context alone does not predict medication response, but understanding these predispositions can provide clinical reasoning support when evaluating options
Cases involve plaintiffs who suffered gastroparesis, pancreatitis, bowel obstruction, vision loss and other serious injuries after taking Ozempic, Wegovy, Rybelsus, or other GLP-1 drugs
doi:10.1371/journal.pone.0127439
Individuals struggling with obesity, insulin resistance, diabetes, unwelcome signs of aging, and hormone imbalances, including thyroid disorders and polycystic ovary syndrome (PCOS), can rely on Transcend Total Body Rejuvenation
They aim to enhance treatment precision, improve safety, and expand global adoption, addressing the growing demand for effective, targeted therapies in diabetes and obesity management and driving innovation and market growth worldwide